Calcitonin
- 1 February 2001
- journal article
- research article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 27 (1) , 187-196
- https://doi.org/10.1016/s0889-857x(05)70193-9
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Effect of the intraperitoneal administration of salmon-calcitonin on the “in vitro” actions of opioid agonistsGeneral Pharmacology: The Vascular System, 1995
- Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation.Journal of Clinical Investigation, 1995
- Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitoninJournal of Bone and Mineral Research, 1994
- A clinical trial on the effects of a combination of elcatonin (Carbocalcitonin) and conjugated estrogens on vertebral bone mass in early postmenopausal womenCalcified Tissue International, 1993
- Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.BMJ, 1992
- Influence of Specific Anti-Salmon Calcitonin Antibodies on Biological Effectiveness of Nasal Salmon Calcitonin in Paget's Disease of BoneScandinavian Journal of Rheumatology, 1990
- Effect of salcatonin given intranasally on early postmenopausal bone loss.BMJ, 1989
- NASAL CALCITONIN FOR TREATMENT OF ESTABLISHED OSTEOPOROSISClinical Endocrinology, 1989
- SIDE-EFFECTS OF SYNTHETIC SALMON AND HUMAN CALCITONINThe Lancet, 1983
- An evaluation of antibodies and clinical resistance to salmon calcitoninJournal of Clinical Investigation, 1972